scholarly journals Alteration in the Efficacy of in Vitro Vancomycin and Ceftazidime Prepared in Normal Saline Versus Balanced Salt Solution in the Management of Ocular Infections

2021 ◽  
pp. 326-331
Author(s):  
Hussain Ahmad Khaqan ◽  
Laraib Hassan ◽  
Sabah Eric ◽  
Hasnain Muhammad Buksh ◽  
Raheela Naz ◽  
...  
Keyword(s):  
Salt Solution ◽  
Normal Saline ◽  
Room Temperature ◽  
Relevant Literature ◽  
Review Article ◽  
Ocular Infections ◽  
The Media ◽  
Search Approach ◽  
Key Terms

Objective: The purpose of this review article is to highlight the efficacy of Vancomycin and Ceftazidime formulated in different solutions for ocular use in the management of microbiological Ocular infections varies. Methodology: To locate and assess all relevant literature, we employed systematic review as a search approach, utilizing punctilious and unambiguous methodologies. We initiated by stipulating key terms and selecting appropriate databases for your literature search. To find replicable and reportable publications from high-quality peer-reviewed journals, we used Google Scholar, PubMed, and Research Gate. Results: Ceftazidime precipitated at 37 degree Celsius, but not at room temperature, however it did not show any effect on the pH of the medium. In both the media of Normal Saline and Balanced Salt Solution, it precipitated on its own or when coupled with vancomycin. Ceftazidime was initially prepared in Balanced Salt Solution rather than Normal Saline, which resulted in further precipitation. Ceftazidime prepared in Normal Saline precipitated to 54% after 168 hours in the dialysis chambers, compared to 88% in Balanced Salt Solution. Ceftazidime synthesized in Normal Saline declined from an initial concentration of 137.5 to 73.4 µg/ml  after 48 hours, while ceftazidime prepared in Balanced Salt Solution decreased to 6.3µg/ml. Vancomycin precipitation was inappreciable. Conclusion: Vancomycin did not precipitate in Normal Saline or Balanced Salt Solution, according to this systemic study. Regardless of the presence of vancomycin, ceftazidime precipitated, and it precipitated more expeditiously if it was produced in Balanced Salt Solution rather than Normal Saline.

scholarly journals THE INFLUENCE THAT SERUM EXERTS UPON TRYPANOSOMES, WITH SPECIAL REFERENCE TO ITS USE FOR EXPERIMENTS IN VITRO WITH ATOXYL AND PARAMINO-PHENYLARSENOXYD

1915 ◽  
Vol 21 (3) ◽  
pp. 250-257 ◽  
Author(s):  
B. T. Terry
Keyword(s):  
Special Reference ◽  
Salt Solution ◽  
Room Temperature ◽  
Toxic Substance ◽  
Normal Morphology ◽  
Undiluted Serum ◽  
Cattle Serum ◽  
Better Than

1. Serum of various animals preserves the motility of nagana trypanosomes better and longer than salt solution. 2. To act best in this way the serum should not be diluted more than 2 to 4 times. Undiluted serum is perhaps best. 3. Serum filtered through a Berkefeld filter, bottled aseptically, and kept in the ice box preserves this activating property apparently undiminished for many months. 4. Serum preserves the motility of trypanosomes better than "Sals physiologicum" of Merck, and better than the Ringer solutions of Meltzer and Carrel. 5. Serum preserves the normal morphology of trypanosomes better than the Ringer solutions tested. 6. The infectiousness of trypanosomes suspended in cattle serum was preserved at room temperature for at least 8 days. 7. The vitality of the trypanosomes in serum was seemingly better preserved at room temperature than at ice box temperature. 8. Serum incubated with atoxyl does not transform it into a toxic substance. 9. Serum does not bind paraminophenylarsenoxyd, for trypanosomes suspended in serum are often immobilized more quickly by paraminophenylarsenoxyd than trypanosomes suspended in salt solution. 10. Serum is suitable for suspending trypanosomes for certain experiments in vitro, and with proper precautions may be employed for transporting virus from laboratory to laboratory.

scholarly journals Changes in Factor VIII:C Activity over 24 Hours Depending on Diluent and Storage Conditions after Dilution

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 2488-2488
Author(s):  
Shin Young Hyun ◽  
Kun soo Lee ◽  
Yu Ri Kim
Keyword(s):  
Factor Viii ◽  
Normal Saline ◽  
Room Temperature ◽  
Conflicts Of Interest ◽  
Distilled Water ◽  
Factor Viii Activity ◽  
Fviii Activity ◽  
Significant Difference ◽  
Over Time

Abstract Background : Continuous infusion of factor VIII (FVIII) is a more cost-effective method for treating hemophilia A than intermittent bolus injection, especially when undergoing surgery. The activity of the factor 8 concentrates may gradually decreases over 24 hours at room temperature, making it difficult to maintain a desired appropriate blood concentration. However, there are no specific guidelines for precise method and duration of continuous intravenous. administration of factor VIII products. In this study, we evaluate in vitro factor VIII activity during 24 hours after reconstitution with diluent fluid in various conditions to propose an effective continuous i.v. infusion method. Method : A total 6 of coagulation factor VIII concentrates were used (2 plasma derived FVIII products and 4 recombinant FVIII products) - Greengene-F®,Advate®, Xyntha®, monoclateP®, Koginate®,Immunate®. Each drug was dissolved in the enclosed water for injection according to the manufacturer's instruction. After 30 minutes of stabilizing, each drug was further diluted in sterilized distilled water or normal saline or dextrose water was adjusted to the same concentration for this experiment. Then, the drugs were stored at refrigeration or room temperature with exposure to light or light-shielded. In vitro FVIII:C was measured at five time points (0, 2, 4, 6, 8, and 24 hours after reconstitution) with a one-stage clotting assay a CS5100 coagulation analyzer system from Sysmex. Then, the factor VIII activity of each time was statistically compared with activity of 0 hour. Results: With all experimental conditions, FVIII activities of all 6 drugs persistently decreased over the course of 24 hours (p <0.001). There was a significant difference in the degree of decrease in activity over time depending on the type of drug (p <0.001), the activity after 2 hours is 47.58 to 90.76 %, the activity after 4 hours is 31.58 to 86.21 %, the activity after 8 hours is 6.49 to 77.03 %, the activity after 18 hours is 2.24 to 75.49 %, the activity after 24 hours is 1.23 to 73.63%. Two hours after the dilution, the FVIII activity decreased to 80% or less with 3 of 6 drugs. After 4 hours, 5 of 6 drugs had the FVIII activity of 80% or less, and after 6 hours the FVIII activity decreased to less than 80% in all of 6 drugs. There was a difference in the degree of decrease in activity depending on the presence or absence of shading and refrigeration, and diluent solutions (normal saline or dextrose water instead of distilled water), but there was a difference between the drugs and consistent correlation was not observed. Conclusions : When the FVIII concentrates were diluted, the activity of each of the six drugs decreased significantly over the 24 hours in vitro, and the degree of decrease was significantly different according to the exposed conditions although there was a difference by drug. Based on the results of the continuous decrease in FVIII activity over time, it is not appropriate to dissolve a 24-hour dose in a large amount of diluted fluid at one time and continuously infuse during 24 hours. Replacing the concentrate before 2 to 6 hours after dilution is probably a better method to maintain desired FVIII activity in patients with hemophilia. Disclosures No relevant conflicts of interest to declare.

In Situ Localization of PPAR Gamma and Uncoupling Protein in Mouse Embryo Sections Using Digoxigenin-Labeled Riboprobes

1996 ◽  
Vol 54 ◽  
pp. 32-33
Author(s):  
C. Jennermann ◽  
S. A. Kliewer ◽  
D. C. Morris
Keyword(s):  
Alkaline Phosphatase ◽  
Room Temperature ◽  
Uncoupling Protein ◽  
Ppar Gamma ◽  
Nuclear Hormone Receptor ◽  
Full Length ◽  
Northern Analysis ◽  
Peroxisome Proliferator

Peroxisome proliferator-activated receptor gamma (PPARg) is a member of the nuclear hormone receptor superfamily and has been shown in vitro to regulate genes involved in lipid metabolism and adipocyte differentiation. By Northern analysis, we and other researchers have shown that expression of this receptor predominates in adipose tissue in adult mice, and appears first in whole-embryo mRNA at 13.5 days postconception. In situ hybridization was used to find out in which developing tissues PPARg is specifically expressed.Digoxigenin-labeled riboprobes were generated using the Genius™ 4 RNA Labeling Kit from Boehringer Mannheim. Full length PPAR gamma, obtained by PCR from mouse liver cDNA, was inserted into pBluescript SK and used as template for the transcription reaction. Probes of average size 200 base pairs were made by partial alkaline hydrolysis of the full length transcripts. The in situ hybridization assays were performed as described previously with some modifications. Frozen sections (10 μm thick) of day 18 mouse embryos were cut, fixed with 4% paraformaldehyde and acetylated with 0.25% acetic anhydride in 1.0M triethanolamine buffer. The sections were incubated for 2 hours at room temperature in pre-hybridization buffer, and were then hybridized with a probe concentration of 200μg per ml at 70° C, overnight in a humidified chamber. Following stringent washes in SSC buffers, the immunological detection steps were performed at room temperature. The alkaline phosphatase labeled, anti-digoxigenin antibody and detection buffers were purchased from Boehringer Mannheim. The sections were treated with a blocking buffer for one hour and incubated with antibody solution at a 1:5000 dilution for 2 hours, both at room temperature. Colored precipitate was formed by exposure to the alkaline phosphatase substrate nitrobluetetrazoliumchloride/ bromo-chloroindlylphosphate.

Kinetics of Various 99mTc-Sn-Pyrophosphate Compounds in the Rat

1977 ◽  
Vol 16 (04) ◽  
pp. 157-162 ◽  
Author(s):  
C. Schümichen ◽  
B. Mackenbrock ◽  
G. Hoffmann
Keyword(s):  
Normal Saline ◽  
Half Life ◽  
Compound A ◽  
Short Half Life ◽  
Low Concentrations ◽  
The Stability ◽  
Kinetics Of ◽  
In Vitro Stability

SummaryThe bone-seeking 99mTc-Sn-pyrophosphate compound (compound A) was diluted both in vitro and in vivo and proved to be unstable both in vitro and in vivo. However, stability was much better in vivo than in vitro and thus the in vitro stability of compound A after dilution in various mediums could be followed up by a consecutive evaluation of the in vivo distribution in the rat. After dilution in neutral normal saline compound A is metastable and after a short half-life it is transformed into the other 99mTc-Sn-pyrophosphate compound A is metastable and after a short half-life in bone but in the kidneys. After dilution in normal saline of low pH and in buffering solutions the stability of compound A is increased. In human plasma compound A is relatively stable but not in plasma water. When compound B is formed in a buffering solution, uptake in the kidneys and excretion in urine is lowered and blood concentration increased.It is assumed that the association of protons to compound A will increase its stability at low concentrations while that to compound B will lead to a strong protein bond in plasma. It is concluded that compound A will not be stable in vivo because of a lack of stability in the extravascular space, and that the protein bond in plasma will be a measure of its in vivo stability.

Evaluation of 99mTc-Label led Vitamin K4 as an Agent for Testicular Imaging

1991 ◽  
Vol 30 (01) ◽  
pp. 35-39 ◽  
Author(s):  
H. S. Durak ◽  
M. Kitapgi ◽  
B. E. Caner ◽  
R. Senekowitsch ◽  
M. T. Ercan
Keyword(s):  
Soft Tissue ◽  
Room Temperature ◽  
Normal Subjects ◽  
Left Testis ◽  
Wide Range ◽  
Activity Ratios ◽  
The Right ◽  
Radioactivity Levels

Vitamin K4 was labelled with 99mTc with an efficiency higher than 97%. The compound was stable up to 24 h at room temperature, and its biodistribution in NMRI mice indicated its in vivo stability. Blood radioactivity levels were high over a wide range. 10% of the injected activity remained in blood after 24 h. Excretion was mostly via kidneys. Only the liver and kidneys concentrated appreciable amounts of radioactivity. Testis/soft tissue ratios were 1.4 and 1.57 at 6 and 24 h, respectively. Testis/blood ratios were lower than 1. In vitro studies with mouse blood indicated that 33.9 ±9.6% of the radioactivity was associated with RBCs; it was washed out almost completely with saline. Protein binding was 28.7 ±6.3% as determined by TCA precipitation. Blood clearance of 99mTc-l<4 in normal subjects showed a slow decrease of radioactivity, reaching a plateau after 16 h at 20% of the injected activity. In scintigraphic images in men the testes could be well visualized. The right/left testis ratio was 1.08 ±0.13. Testis/soft tissue and testis/blood activity ratios were highest at 3 h. These ratios were higher than those obtained with pertechnetate at 20 min post injection.99mTc-l<4 appears to be a promising radiopharmaceutical for the scintigraphic visualization of testes.

Effect of Temperature on ADP-Induced Platelet Aggregation

1973 ◽  
Vol 29 (01) ◽  
pp. 183-189
Author(s):  
C. A Praga ◽  
E. M Pogliani
Keyword(s):  
Platelet Aggregation ◽  
Incubation Period ◽  
Room Temperature ◽  
Important Variable ◽  
Practical Significance ◽  
Effect Of Temperature ◽  
Induce Platelet Aggregation ◽  
Cuvette Holder ◽  
Exact Temperature

SummaryTemperature represents a very important variable in ADP-induced platelet aggregation.When low doses of ADP ( < 1 (μM) are used to induce platelet aggregation, the length of the incubation period of PRP in the cuvette holder of the aggregometer, thermostatted at 37° C, is very critical. Samples of the same PRP previously kept at room temperature, were incubated for increasing periods of time in the cuvette of the aggregometer before adding ADP, and a significant decrease of aggregation, proportional to the length of incubation, was observed. Stirring of the PRP during the incubation period made these changes more evident.To measure the exact temperature of the PRP during incubation in the aggre- gometer, a thermocouple device was used. While the temperature of the cuvette holder was stable at 37° C, the PRP temperature itself increased exponentially, taking about ten minutes from the beginning of the incubation to reach the value of 37° C. The above results have a practical significance in the reproducibility of the platelet aggregation test in vitro and acquire particular value when the effect of inhibitors of ADP induced platelet aggregation is studied.Experiments carried out with three anti-aggregating agents (acetyl salicyclic acid, dipyridamole and metergoline) have shown that the incubation conditions which influence both the effect of the drugs on platelets and the ADP breakdown in plasma must be strictly controlled.

Human Platelet Acetylcholinesterase: The Effects of Anticholinesterases on Platelet Function

1979 ◽  
Vol 42 (05) ◽  
pp. 1615-1619 ◽  
Author(s):  
Martin J Smith ◽  
Boyd Braem ◽  
Kent D Davis
Keyword(s):  
Platelet Function ◽  
Ache Activity ◽  
Room Temperature ◽  
Platelet Rich Plasma ◽  
Complete Inhibition ◽  
Clot Retraction ◽  
Plasma Clot ◽  
Normal Platelet ◽  
Aggregation Factor

SummaryPlatelet acetylcholinesterase (AChE) activity was measured in gel-filtered platelet preparations. Three different anticholinesteratic agents (eserine, neostigmine, and diiso- propylphosphorofluoridate) at final concentrations of 10 μM caused complete inhibition of AChE activity after 30 min incubation at room temperature with either platelet-rich plasma or gel-filtered platelets. Complete inhibition of platelet AChE had no effect on platelet aggregation, factor-3 availability, and plasma clot retraction. We conclude that platelet membrane AChE activity is not required for normal platelet function as measured by these in vitro parameters.

PERILAKU DISOLUSI KETOPROFEN DAN INDOMETASIN FARNESIL TERSALUT GEL KITOSAN-GOM GUAR

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Purwantiningsih Sugita ◽  
Bambang Srijanto ◽  
Budi Arifin ◽  
Fithri Amelia ◽  
Mahdi Mubarok
Keyword(s):  
Room Temperature ◽  
Guar Gum ◽  
Tween 80 ◽  
Chitosan Solution ◽  
In Vitro Dissolution ◽  
Dissolution Profile ◽  
Magnetic Stirrer ◽  
Dissolution Behaviour ◽  
Shrimp Shell Waste

Chitosan, a modification of shrimp-shell waste, has been utilized as microcapsule. However, it’s fragile gel property needs to be strengthened by adding glutaraldehyde (glu) and natural hydrocolloid guar gum (gg). This research’s purposes were to study dissolution behaviour of ketoprofen and infar through optimum chitosan-guar gum microcapsule. Into 228.6 mL of 1.75% (w/v) chitosan solution in 1% (v/v) acetic acid,38.1 mL of gg solution was added with concentration variation of 0.35, 0.55, and 0.75% (w/v) for ketoprofen microcapsules and 0.05, 0.19, and 0.33% (w/v) for infar microcapsules, and stirred with magnetic stirrer until homogenous. Afterwards, 7.62mL of glu was added slowly under stirring, with concentrations varied: 3, 3.5, and 4% (v/v) for ketoprofen microcapsules, and 4, 4.5, and 5% (v/v) for infar microcapsules. All mixtures were shaked for 20 minutes for homogenization. All mixtures wereshaked for 20 minutes for homogenization. Into each  microcapsule mixture for ketoprofen, a solution of 2 g of ketoprofen in 250 mL of 96% ethanol was added, whereas solution of 100 mg of in 250 mL of 96% ethanol was added into each microcapsule mixture for infar. Every mixture was then added with 5 mL of 2% Tween-80 and stirred with magnetic stirrer for an hour at room temperature. Everymixture was then added with 5 mL of 2% Tween-80 and stirred with magnetic stirrer for an hour at room temperature. Conversion of suspension into fine powders/granules (microcapsules) was done by using spray dryer. The data of [gg], [glu], and medicine’s content from each microcapsule were treated with Minitab 14 software to obtain optimum [gg] and [glu] for microencapsulation. The dissolution behaviour of optimum ketoprofen and infar microcapsules were investigated. The result of optimization by using Minitab Release 14 software showed that among the microcapsule compositions of [gg] and [glu] were 0.35% (w/v) and 3.75% (v/v), respectively, optimum to coat ketoprofen, whereas [gg] and [glu] of 0.05% (w/v) and4.00% (v/v), respectively, optimum to coat infar, at constant chitosan concentration (1.75% [w/v]). In vitro dissolution profile showed that chitosan-guar gum gel microcapsule was more resistant in intestinal pH condition (rather basic) compared with that in gastric pH (very acidic).

Extract of Polyphenols from Pomegranate Seed and its Antioxidant Activity in Vitro

2020 ◽  
Vol 71 (6) ◽  
pp. 492-499
Author(s):  
Le-Bin Yin ◽  
Dan Liu ◽  
Ai-Lian Yang ◽  
Cong Liao ◽  
Ping He ◽  
...  
Keyword(s):  
Superoxide Anion ◽  
Room Temperature ◽  
Dpph Radical ◽  
Interaction Technique ◽  
Alcohol Extract ◽  
Effective Components ◽  
Pomegranate Seed ◽  
Pomegranate Seeds ◽  
Scavenging Rates

In this study, the pomegranate seeds were treated by micro-cutting assisted interaction technique. The effective components were extracted from pomegranate seeds with 95% ethanol at room temperature, and their antioxidant capacity in vitro was determined. The results showed that the scavenging rates of DPPH radical, superoxide anion radical, hydroxyl radical and lipid peroxidation were 70.97, 51.95, 52.85, and 80.62%, respectively. The antioxidation ability of alcohol extract of pomegranate seed was studied in order to provide theoretical basis for developing more value of pomegranate seed in the future.

Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19

2020 ◽  
Vol 21 (6) ◽  
pp. 427-435 ◽  
Author(s):  
Cheng Cui ◽  
Siqi Tu ◽  
Valerie Sia Jie En ◽  
Xiaobei Li ◽  
Xueting Yao ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Clinical Efficacy ◽  
Relevant Literature ◽  
The United States ◽  
Efficacy And Safety ◽  
Open Label ◽  
Infected People ◽  
Treatment Regimens ◽  
Therapeutic Drugs

Background: As the number of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infected people is greatly increasing worldwide, the international medical situation becomes very serious. Potential therapeutic drugs, vaccine and stem cell replacement methods are emerging, so it is urgent to find specific therapeutic drugs and the best treatment regimens. After the publications on hydroxychloroquine (HCQ) with anti- SARS-COV-2 activity in vitro, a small, non-randomized, open-label clinical trial showed that HCQ treatment was significantly associated with reduced viral load in patients with coronavirus disease-19 (COVID-19). Meanwhile, a large prophylaxis study of HCQ sulfate for COVID-19 has been initiated in the United States. HCQ offered a promising efficacy in the treatment of COVID-19, but the optimal administration is still being explored. Methods: We used the keyword "hydroxychloroquine" to conduct a literature search in PubMed to collect relevant literature on the mechanism of action of HCQ, its clinical efficacy and safety, pharmacokinetic characteristics, precautions for clinical use and drug interactions to extract and organize information. Results: This paper reviews the mechanism, clinical efficacy and safety, pharmacokinetic characteristics, exposureresponse relationship and precautions and drug interactions of HCQ, and summarizes dosage recommendations for HCQ sulfate. Conclusion: It has been proved that HCQ, which has an established safety profile, is effective against SARS-CoV-2 with sufficient pre-clinical rationale and evidence. Data from high-quality clinical trials are urgently needed worldwide.

Sign in / Sign up

Export Citation Format

Share Document